TFP
CME icon

Tilia Fiduciary Partners’s CME Group CME Stock Holding History

Tilia Fiduciary Partners’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-277
Closed -$51.3K – 163
2023
Q2 		$51.3K Buy
277
+1
+0.4% +$185 0.05% 210
2023
Q1 		$52.8K Buy
276
+2
+0.7% +$362 0.05% 202
2022
Q4 		$46.1K Buy
274
+1
+0.4% +$174 0.04% 209
2022
Q3 		$46K Buy
273
+1
+0.4% +$198 0.05% 206
2022
Q2 		$55K Buy
272
+1
+0.4% +$212 0.05% 194
2022
Q1 		$64K Buy
271
+1
+0.4% +$235 0.05% 198
2021
Q4 		$62K Buy
+270
New +$59.4K 0.05% 199

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Tilia Fiduciary Partners's CME Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of CME Group (CME) in Q3 2023, closing a stake of 277 shares — an estimated $51.3K sold.

Tilia Fiduciary Partners first reported a position in CME in Q4 2021 and held it in 7 quarters. The position peaked at $64K in Q1 2022. 1,230 funds tracked by Wall St. Rank hold CME as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining CME Group position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 277 CME Group shares in Q3 2023, an estimated $51.3K.
  • Tilia Fiduciary Partners first reported a position in CME Group in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's CME Group position peaked at $64K in Q1 2022.
  • 1,230 funds tracked by Wall St. Rank held CME Group as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.